Calendar Arbutus Biopharma Corporation

Equities

ABUS

CA03879J1003

Biotechnology & Medical Research

Delayed Nasdaq Other stock markets 04:00:00 2025-06-18 pm EDT			5-day change	1st Jan Change
3.470 ^USD	+0.58%		-0.86%	+6.12%

May. 14	Arbutus Biopharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
May. 07	Arbutus Biopharma Corporation Presents Clinical Trial Data from Its Two HBV Assets, Imdusiran and AB-101, At the European Association for the Study of the Liver Congress 2025	CI

Chart calendar Arbutus Biopharma Corporation

c82c7d5fe850.yxOupDCn_EGBjP_rlA9ghWpjON6FiY7WM91jYU18GOM.nUrvzlbQtRDvusmS-mwW7h4CdZTqz7fgfOURUQcKfauMItSWAJKjeNG1mA~f2a5fdfb3b492ea46168f0034c48e8bf

Upcoming events on Arbutus Biopharma Corporation

2025-07-30	Q2 2025 Earnings Release (Projected)
2025-11-04	Q3 2025 Earnings Release (Projected)
2026-02-25	Q4 2025 Earnings Release (Projected)
2026-04-29	Q1 2026 Earnings Release (Projected)

Past events on Arbutus Biopharma Corporation

2025-05-21 10:00 am	Annual General Meeting
2025-05-14 07:30 am	Q1 2025 Earnings Release
2025-03-27 07:30 am	Q4 2024 Earnings Release
2024-12-03 11:00 am	Investor Meeting - H.C Wainwright
2024-11-21 07:00 am	Jefferies London Healthcare Conference
2024-11-15 11:00 am	American Association for the Study of Liver Disease Meeting - Soluble Immune Biomarker Profiling of
2024-11-15 11:00 am	American Association for the Study of Liver Disease Meeting - HBV Target Site for the RNA Interferen
2024-11-06 08:45 am	Q3 2024 Earnings Call
2024-11-06 07:30 am	Q3 2024 Earnings Release
2024-10-08 01:30 pm	H.C. Wainwright Viral Hepatitis Virtual Conference
2024-09-10 08:30 am	Baird Global Healthcare Conference
2024-09-09 08:00 am	H.C. Wainwright Global Investment Conference
2024-08-01 08:45 am	Q2 2024 Earnings Call
2024-08-01 07:30 am	Q2 2024 Earnings Release
2024-06-05	European Association for the Study of the Liver Congress - Abstract Number : 505
2024-06-05 09:30 am	Jefferies Global Healthcare Conference
2024-06-04	European Association for the Study of the Liver Congress - Abstract Number : 2389
2024-05-22 10:00 am	Annual General Meeting
2024-05-20 03:30 pm	H.C. Wainwright BioConnect Investor Conference - Fireside Chat
2024-05-14 09:30 am	Citizens JMP Life Sciences Conference - Fireside Chat

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026
Net sales Million CAD	Released Forecast Spread	53,1 52,5 1.25%	24,6 28,3 -13.05%	8,80 8,72 0.9%	7,85	6,18
EBITDA	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00	0,00
EBIT Million CAD	Released Forecast Spread	-89,1 -85,3 -4.45%	-106 -108 2.15%	-109 -113 3.34%	-59,1	0,00
Earnings before Tax (EBT) Million CAD	Released Forecast Spread	-88,5 -85,5 -3.55%	-98,9 -101 2.23%	-99,7 -103 3.31%	-52,5	0,00
Net income Million CAD	Released Forecast Spread	-94,6 -90,7 -4.27%	-98,9 -99,8 0.86%	-99,7 -103 3.31%	-52,5	0,00
EPS CAD	Released Forecast Spread	-0,63 -0,61 -2.9%	-0,60 -0,61 1.69%	-0,54 -0,55 1.05%	-0,37	-0,34
Announcement Date		02/03/23	29/02/24	27/03/25	-

Quarterly results

Fiscal Period	March	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million CAD	Released Forecast Spread	6,37 6,41 -0.54%	2,91 6,51 -55.28%	2,11 3,68 -42.75%	2,39 2,42 -1.06%	1,86 2,57 -27.91%	2,25 2,21 1.69%	2,46 2,29 7.78%	2,22	2,19	1,00	1,86	1,86	1,86	1,79
EBIT Million CAD	Released Forecast Spread	-29,5 -28,0 -5.14%	-28,2 -30,1 6.48%	-26,6 -27,7 3.95%	-29,9 -26,8 -11.57%	-29,7 -27,3 -8.93%	-19,9 -24,6 19.08%	-35,9 -27,3 -31.34%	-8,24	-7,68	-7,12
Earnings before Tax (EBT) Million CAD	Released Forecast Spread	-27,5 -26,9 -2.13%	-26,2 -28,2 6.88%	-24,6 -25,8 4.7%	-27,4 -24,7 -10.89%	-27,3 -24,8 -10.3%	-17,9 -22,1 19.24%	-34,3 -25,3 -35.42%	-6,71	-6,15	-5,59
Net income Million CAD	Released Forecast Spread	-27,5 -26,9 -2.13%	-26,2 -28,2 6.88%	-24,6 -25,8 4.7%	-27,4 -24,7 -10.97%	-27,3 -24,8 -10.26%	-17,9 -22,1 19.24%	-34,3 -25,3 -35.42%	-6,71	-6,15	-5,59
EPS CAD	Released Forecast Spread	-0,16 -0,15 -6.56%	-0,16 -0,16 -1.19%	-0,14 -0,15 7.81%	-0,15 -0,13 -15.73%	-0,14 -0,13 -6.91%	-0,10 -0,11 11.48%	-0,18 -0,15 -22.23%	-0,07	-0,06	-0,06	-0,08	-0,08	-0,08	-0,08
Announcement Date		07/11/23	29/02/24	02/05/24	01/08/24	06/11/24	27/03/25	14/05/25	-	-	-	-	-	-	-

Upcoming sector events for Arbutus Biopharma Corporation

2025-07-22	ALKERMES PLC: Q2 2025 Earnings Release (Projected)
2025-07-22	ICON PUBLIC LIMITED COMPANY: Q2 2025 Earnings Release (Projected)
2025-07-22	SYNGENE INTERNATIONAL LIMITED: Q1 2026 Earnings Release (Projected)
2025-07-22	LONZA GROUP AG: Q2 2025 Earnings Release
2025-07-23 04:01 pm	GALAPAGOS NV: Q2 2025 Earnings Release
2025-07-23	EUROFINS SCIENTIFIC SE: Q2 2025 Earnings Release
2025-07-24 01:00 am	BACHEM HOLDING AG: Q2 2025 Earnings Release
2025-07-24	PHARVARIS N.V.: Q2 2025 Earnings Release (Projected)
2025-07-25 01:00 am	BB BIOTECH AG: Q2 2025 Earnings Release
2025-07-27	MEDPACE HOLDINGS, INC.: Q2 2025 Earnings Release (Projected)

More events

Past sector events for Arbutus Biopharma Corporation

2025-06-10 03:20 am	POLARIS GROUP: May 2025 Sales and Revenue Release
2025-05-29 07:00 am	IMMUNOVANT, INC.: Q4 2025 Earnings Release
2025-05-27	MESOBLAST LIMITED: Q3 2025 Earnings Release (Projected)
2025-05-22 07:00 am	REPLIMUNE GROUP, INC.: Q4 2025 Earnings Release
2025-05-21 02:00 am	BIOARCTIC AB: Q1 2025 Earnings Release
2025-05-20	EXSCIENTIA PLC: Q1 2025 Earnings Release (Projected)
2025-05-20 07:00 am	CUREVAC N.V.: Q1 2025 Earnings Release
2025-05-14	GI INNOVATION, INC.: Q1 2025 Earnings Release
2025-05-14	GNI GROUP LTD.: Q1 2025 Earnings Release
2025-05-14 04:32 pm	SS INNOVATIONS INTERNATIONAL, INC.: Q1 2025 Earnings Release